121 related articles for article (PubMed ID: 6253429)
1. Antibacterial activity of a new cephalosporin, cefotaxime.
Russell AD; Rogers DT
J Appl Bacteriol; 1980 Aug; 49(1):137-41. PubMed ID: 6253429
[No Abstract] [Full Text] [Related]
2. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
Rogers DT; Russell AD
J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086
[No Abstract] [Full Text] [Related]
3. [Evaluation of the antibacterial activity in vitro of various cephalosporins on different gram-negative bacterial species of recent clinical isolation].
Piccolomini R; Di Sipio L; Ravagnan G
Boll Soc Ital Biol Sper; 1980 Jan; 56(2):133-9. PubMed ID: 6776969
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a series of parenteral 3'-quaternary ammonium cephalosporins.
Brown RF; Kinnick MD; Morin JM; Vasileff RT; Counter FT; Davidson EO; Ensminger PW; Eudaly JA; Kasher JS; Katner AS
J Med Chem; 1990 Aug; 33(8):2114-21. PubMed ID: 2115587
[TBL] [Abstract][Full Text] [Related]
5. Ability of ceftibuten to induce the class-I beta-lactamases of Enterobacter cloacae, Serratia marcescens, and Enterobacter aerogenes.
Papanicolaou GA; Medeiros AA
Diagn Microbiol Infect Dis; 1991; 14(1):85-7. PubMed ID: 2013214
[TBL] [Abstract][Full Text] [Related]
6. Enzyme kinetic studies with beta-lactamases against cefotaxime and other cephalosporins.
Yan SY; Li JT
Chin Med J (Engl); 1987 Dec; 100(12):940-4. PubMed ID: 3133166
[No Abstract] [Full Text] [Related]
7. Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1980 Apr; 17(4):583-90. PubMed ID: 6967294
[TBL] [Abstract][Full Text] [Related]
8. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
Washington JA II
J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
[TBL] [Abstract][Full Text] [Related]
9. Emergence of beta-lactam multiresistant variants of gram-negative bacilli in the presence of cefotaxime.
Svarva PL; Lyng RV; Maeland JA
Scand J Infect Dis; 1985; 17(4):387-91. PubMed ID: 3911375
[TBL] [Abstract][Full Text] [Related]
10. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
Ramadan MA; Tawfik AF; Shibl AM
Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
[TBL] [Abstract][Full Text] [Related]
11. Chemistry of cephalosporin antibiotics. 28. Preparation and biological activity of 3-(substituted)vinyl cephalosporins.
Webber JA; Ott JL; Vasileff RT
J Med Chem; 1975 Oct; 18(10):986-92. PubMed ID: 808607
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefetamet against enterobacteria expressing an SHV-5-type beta-lactamase.
Tzouvelekis LS; Prinarakis EE; Gazouli M; Miriagou V; Tzelepi E; Legakis NJ
Chemotherapy; 1996; 42(5):324-8. PubMed ID: 8874970
[TBL] [Abstract][Full Text] [Related]
14. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Concia E; Marone P; Verani D; Marino P
Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
[TBL] [Abstract][Full Text] [Related]
15. Lytic activity of a new cephalosporin, cefuroxime, against gram-negative bacteria.
Russell AD; Tottle PC
Chemotherapy; 1978; 24(6):354-9. PubMed ID: 359269
[TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of clinical isolates to aztreonam].
Nagasawa Z; Nishimura T; Nagumo F; Ueda H; Tadano J; Katoh O; Yamada H
Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799
[TBL] [Abstract][Full Text] [Related]
17. In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated at 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
Int J Antimicrob Agents; 2000 Jul; 15(2):111-8. PubMed ID: 10854806
[TBL] [Abstract][Full Text] [Related]
18. 3-trifluoromethylcarbacephems: synthesis of broad spectrum antibacterial compounds.
Cook GK; Hornback WJ; McDonald JH; Munroe JE; Snyder NJ
Bioorg Med Chem Lett; 1998 May; 8(10):1261-6. PubMed ID: 9871746
[TBL] [Abstract][Full Text] [Related]
19. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
Bartmann K; Tarbuc R
Infection; 1982; 10(6):361-70. PubMed ID: 6818153
[TBL] [Abstract][Full Text] [Related]
20. A comparison of cefamandole, cefoxitin, cefuroxime, cefotaxime and cefoperazone: an in vitro test on a number of beta-lactamase producing strains of 9 species and 1 genus of bacteria.
Kuipers JS
Curr Med Res Opin; 1981; 7(3):196-203. PubMed ID: 6971210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
